Cellebrite DI Ltd.CLBTEarnings & Financial Report
Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.
Revenue
$232.1M
Gross Profit
$193.8M
Operating Profit
$18.2M
Net Profit
N/A
Gross Margin
83.5%
Operating Margin
7.9%
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.35
Financial Flow
Cellebrite DI Ltd. Q3 2024 Financial Summary
Cellebrite DI Ltd. reported revenue of $232.1M for Q3 2024, with a net profit of N/A (N/A margin). Cost of goods sold was $38.3M, operating expenses totaled $175.5M.
Key Financial Metrics
| Total Revenue | $232.1M |
|---|---|
| Net Profit | N/A |
| Gross Margin | 83.5% |
| Operating Margin | 7.9% |
| Report Period | Q3 2024 |
Revenue Breakdown
Cellebrite DI Ltd. Q3 2024 revenue of $232.1M breaks down across 4 segments, led by Subscription services at $152.0M (65.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Subscription services | $152.0M | 65.5% |
| Term-license | $49.7M | 21.4% |
| Professional services | $21.3M | 9.2% |
| Other non-recurring | $9.1M | 3.9% |
Cellebrite DI Ltd. Revenue by Segment — Quarterly Trend
Cellebrite DI Ltd. revenue by segment across the last 4 reported quarters, showing how each business line (such as Subscription services and Term-license) has evolved quarter over quarter.
| Segment | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Subscription services | $197.2M | — | $62.1M | $152.0M |
| Term-license | $60.8M | — | $17.1M | $49.7M |
| Professional services | $23.2M | — | $6.8M | $21.3M |
| Other non-recurring | $11.0M | — | $3.6M | $9.1M |
Cellebrite DI Ltd. Quarterly Revenue & Net Profit History
Cellebrite DI Ltd. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 2025 | $292.2M | — | $-302.3M | -103.5% |
| Q2 2025 | $220.8M | +19.2% | $36.9M | 16.7% |
| Q1 2025 | $89.6M | — | $-71.4M | -79.7% |
| Q3 2024 | $232.1M | — | N/A | N/A |
| Q2 2024 | $185.3M | +89.3% | $-95.2M | -51.4% |
| Q1 2024 | $71.2M | — | $-40.6M | -57.0% |
| Q3 2023 | $196.6M | — | $113.7M | 57.8% |
| Q2 2023 | $97.9M | +39.1% | $-73.0M | -74.5% |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $97.9M | $196.6M | $71.2M | $185.3M | $232.1M | $89.6M | $220.8M | $292.2M |
| YoY Growth | 39.1% | N/A | N/A | 89.3% | N/A | N/A | 19.2% | N/A |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $425.9M | $403.3M | $532.9M | $556.6M | $532.9M | $690.6M | $787.4M | $690.6M |
| Liabilities | $408.3M | $329.4M | $498.7M | $596.7M | $498.7M | $354.5M | $379.0M | $354.5M |
| Equity | $17.6M | $73.9M | $34.2M | $-40.2M | $34.2M | $336.0M | $408.4M | $336.0M |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $29.1M | $-15.2M | $12.5M | $24.6M | $58.2M | $10.0M | $53.5M | $66.2M |